Home » ETF » FBT

FBT - First Trust NYSE Arca Biotechnology Index Fund

Stock Price: $162.08 USD 0.90 (0.56%)
Updated Apr 20, 2021 4:00 PM EDT - Market closed
Assets $1.88B
NAV $161.07
Expense Ratio 0.55%
PE Ratio 25.85
Beta (5Y) 1.02
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date Sep 23, 2015
1-Year Return -
Trading Day April 20
Last Price $162.08
Previous Close $161.18
Change ($) 0.90
Change (%) 0.56%
Day's Open 160.41
Day's Range 160.09 - 162.34
Day's Volume 72,213
52-Week Range 146.10 - 186.51

Fund Description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.

Asset Class
Equity
Sector
Biotech
Region
Global
Inception Date
Jun 19, 2006
Exchange
NYSEARCA
Ticker Symbol
FBT
Index Tracked
NYSE Arca Biotechnology Index

Top 10 Holdings

33.83% of assets
NameSymbolWeight
Grifols S.A.GRFS3.44%
IlluminaILMN3.40%
Alexion PharmaceuticalsALXN3.39%
AlkermesALKS3.39%
ExelixisEXEL3.38%
IQVIA HoldingsIQV3.37%
Charles River LaboratoriesCRL3.37%
BioMarin PharmaceuticalBMRN3.37%
AmgenAMGN3.36%
United TherapeuticsUTHR3.36%
View More Holdings

News

Hide News
  • All
  • Videos
  • Conversation

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

Other tickers mentioned: AZN, BBH, BNTX, BTEC, IBB, MRNA, NVAX ...
1 week ago - Zacks Investment Research

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

Other tickers mentioned: ARKG, BBH, BNTX, BTEC, CNCR, IBB, PBE ...
3 months ago - Zacks Investment Research

Two ETF experts share their market outlook and top picks for 2021.

Other tickers mentioned: ARKG, EDOC, EES, ICLN, KBWB, ONLN, QQQM ...
3 months ago - Zacks Investment Research

AstraZeneca has agreed to buy rare-disease specialist Alexion Pharmaceuticals for $39 billion. The deal would represent the biggest transaction in pharmaceuticals since 2019.

Other tickers mentioned: BBH, PBE, PJP, PPH
4 months ago - Zacks Investment Research

The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weekend when AstraZeneca (NYSE: AZN) announced a $39-billion takeover of Alexion ...

Other tickers mentioned: BBH, PBE
4 months ago - Benzinga

The introduction of the coronavirus vaccine is expected to help in the economic recovery, especially for sectors which have taken a hit from the social-distancing and lockdown measures.

Other tickers mentioned: CARZ, IBB, JETS, KBWB, KRE, PEJ, XBI ...
4 months ago - Zacks Investment Research

As coronavirus cases start to tick upwards once more, the race to create a vaccine will only intensify, boding well for the biotechnology sector. ETF investors may want to keep an eye on biotech funds, ...

Other tickers mentioned: ARKG, BBH, XBI
5 months ago - ETF Trends

As the race to develop a vaccine continues, these biotech stocks could be high risk, high return propositions. The post 7 Biotech Stocks To Buy For Profit From The Vaccine Crunch appeared first on Inves...

Other tickers mentioned: GILD, GERM, PFE, REGN, WST
6 months ago - InvestorPlace

Johnson & Johnson's entry into the late-stage trials has increased optimism in the coronavirus vaccine development.

Other tickers mentioned: ARKG, BBH, IBB, XBI
6 months ago - Zacks Investment Research

Not all healthcare ETFs are the same and as this group of three proves, that can be a positive for savvy investors. The post 3 Healthcare ETFs to Buy for Health and Safety appeared first on InvestorPlace.

Other tickers mentioned: EDOC, TDOC
7 months ago - InvestorPlace

Healthcare is one of the most politically sensitive sectors and that sensitivity is on full display in recent weeks with biotechnology ETFs, including the First Trust NYSE Arca Biotechnology Index Fund ...

7 months ago - ETF Trends

Nine vaccine developers have jointly pledged to observe high ethical standards in conducting clinical studies and manufacturing of vaccines.

Other tickers mentioned: ARKG, BBH, IBB, XBI
7 months ago - Zacks Investment Research

Biotechnology exchange-traded funds were hot until they weren't. History indicates recent weakness in the previously high-flying group be a symptom of election year jitters and investors shouldn't ignor...

7 months ago - Benzinga

AstraZeneca's initiation of a phase III study has heated up competition to bring a coronavirus vaccine to the markets.

Other tickers mentioned: ARKG, BBH, IBB, XBI
7 months ago - Zacks Investment Research

These days, it's not hard to find winners among health care exchange-traded funds and that's true of both established and rookie players.

8 months ago - Benzinga

Biotech ETFs are popular and delivering for investors, but not all of these funds need the Covid-19 pandemic to soar.

Other tickers mentioned: ARKG, BTEC, CNCR, GERM, SBIO, XBI
8 months ago - InvestorPlace

Let's check out some ETF areas that will remain solid investment picks even as the coronavirus cases show a sharp spike.

Other tickers mentioned: ARKW, ESGU, ESGV, FDN, IBB, OGIG, PNQI ...
8 months ago - Zacks Investment Research

Two major vaccine developers' entrance into the final stage trials is expected to boost investor optimism.

Other tickers mentioned: ARKG, BBH, IBB, XBI
8 months ago - Zacks Investment Research

The race to find a coronavirus vaccine is heating up as the latest positive data from progress in trials are being published.

Other tickers mentioned: ARKG, BBH, IBB, XBI
8 months ago - Zacks Investment Research

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

Other tickers mentioned: MRNA, BBH, BTEC, CNCR, GERM, IBB, IDNA ...
9 months ago - Zacks Investment Research

Here we highlight three sectors that are sizzling with investing opportunities as the second wave of the outbreak is gathering steam.

Other tickers mentioned: FTEC, IBB, ITB, IYW, PKB, VGT, XBI ...
9 months ago - Zacks Investment Research

As the coronavirus outbreak continues to aggravate, investors are eyeing developments in vaccine or treatments to combat the pandemic.

Other tickers mentioned: ARKG, BBH, IBB, XBI
9 months ago - Zacks Investment Research

In the continuing quest to find a vaccine for the coronavirus, the World Health Organization announced Wednesday it is dropping hydroxychloroquine, the malaria drug backed by President Trump, who claims...

Other tickers mentioned: BBH
10 months ago - ETF Trends

While the Coronavirus pandemic continues dominating healthcare sector headlines, investors shouldn’t fret that biotechnology ETFs will be left vulnerable when the virus is finally vanquished. That’s goo...

10 months ago - ETF Trends

The S&P 500’s top five stocks account for 19.8% of the index’s total weight. These seven index funds avoid getting top-heavy.

Other tickers mentioned: EQL, EUSA, IBUY, RSP, VRAI, XNTK
10 months ago - InvestorPlace

Here we take a look at how the latest updates on drugs, antibody therapies and vaccines targeted at winning the coronavirus battle can affect biotech ETFs.

Other tickers mentioned: ARKG, BBH, IBB, XBI
10 months ago - Zacks Investment Research

Novavax's latest progress in the Covid-19 vaccine development brings optimism to the Wall Street.

Other tickers mentioned: ARKG, BBH, IBB, XBI
10 months ago - Zacks Investment Research

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

Other tickers mentioned: BBH, CNCR, IBB, IDNA, IHE, IHF, PBE ...
11 months ago - Zacks Investment Research

We have presented a bunch of five top-performing ETFs of the 11-year bull market that will continue to outperform in the coming months given that these have a solid Zacks Rank.

Other tickers mentioned: IGV, PNQI, QTEC, SOXX
1 year ago - Zacks Investment Research

These sector ETFs emerged winners in the 11-year old bull market and may survive despite the coronavirus scare.

Other tickers mentioned: FDN, FXH, PJP, QTEC, VCR, XBI, XLY
1 year ago - Zacks Investment Research

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their Q4 earnings releases.

Other tickers mentioned: BBH, IBB, XBI
1 year ago - Zacks Investment Research

Companies in the biotech industry face an incredible amount of risk while getting their drugs to market.

Other tickers mentioned: BBH, IBB, XBI
1 year ago - 24/7 Wall Street

As ETF investing constantly climbs the popularity charts, we highlight a few good ETF areas that investors can bank on for 2020.

Other tickers mentioned: BBH, EEM, IBB, ICLN, ITB, PALL, PKB ...
1 year ago - Zacks Investment Research

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

Other tickers mentioned: ARKG, BBH, BBP, BTEC, CNCR, IBB, PBE ...
1 year ago - Zacks Investment Research

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to drive the biotech market.

Other tickers mentioned: BBH, CRSP, GBT, IBB, NVS, VRTX, XBI
1 year ago - Zacks Investment Research

While the rest of the biotechnology sector remained depressed along with the broader markets, related exchange traded funds found strength from an unexpected surge in ACADIA Pharmaceuticals (NasdaqGS: A...

Other tickers mentioned: BBP, IBB, SBIO
1 year ago - ETF Trends

Biotech stocks fall after Trump promises executive order drug prices

YouTube video

CNBC's Meg Tirrell reports on the dip in biotech stocks after President Donald Trump promised that an executive order on drug prices is coming.

Other tickers mentioned: ARKG, FHLC, IBB, LABU, RYH, VHT, XBI ...
1 year ago - CNBC Television

The U.S. economy has stepped into the 11th year of the expansion, exhibiting the longest expansion in history. These winning ETFs and stocks will rally further.

Other tickers mentioned: FDN, ITA, XLY
1 year ago - Zacks Investment Research

When the stock market is hitting record highs, it’s important to remember that it’s really a market of stocks rather than a stock market. Not all companies are created equal. Nor are all sectors.

Other tickers mentioned: AMGN, ARKG, BBH, BIIB, BMY, CELG, GILD ...
1 year ago - 24/7 Wall Street

M&A activity, approval of novel drugs and earnings growth in Q1 put healthcare ETFs in a decent spot.

Other tickers mentioned: BBH, BTEC, IYH, VHT
2 years ago - Zacks Investment Research

Is now the time to buy Nike? What about biotech? #AskHalftime

YouTube video

The "Halftime Report" traders take viewer questions on Nike and biotech.

Other tickers mentioned: IBB, NKE, XBI
2 years ago - CNBC Television